default author photo

Rui Mao

affiliation not provided to SSRN

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Osimertinib after definitive chemoradiotherapy in patients with unresectable stage III EGFR-mutated NSCLC: LAURA China cohort

Number of pages: 26 Posted: 24 Dec 2025
Huazhong University of Science and Technology, Shanghai Jiao Tong University (SJTU) - Department of Medical Oncology, Sichuan University - Department of Thoracic Oncology, Shandong First Medical University - Shandong Cancer Hospital and Institute, Fudan University - Department of Radiation Oncology, Zhengzhou University - Henan Provincial People's Hospital, Sun Yat-sen University (SYSU), Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology, Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, affiliation not provided to SSRN, Wenzhou Medical University - Affiliated Taizhou Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Shanghai Jiao Tong University (SJTU) - Shanghai Lung Cancer Center
Downloads 36 (1,236,159)

Abstract:

Loading...

Osimertinib, Chemoradiotherapy, China, EGFR-mutated